The new millennium began with a bang at OMRF, as Dr. Jordan Tang, above, and his research team identified and cloned the enzyme believed to cause Alzheimer’s disease. Soon after, the OMRF scientists designed an inhibitor that stopped the enzyme in its tracks. The discoveries led to the development of an experimental drug acquired by […]
alzheimer's disease
OMRF receives grant for Alzheimer’s research
The National Institutes of Health has awarded the Oklahoma Medical Research Foundation $480,000 for research on dopamine’s role in Alzheimer’s disease.
Will new Alzheimer’s drug deliver more than profits?
A new Alzheimer’s drug. That has always been the dream.
